Role of Thymus and Activation-Regulated Chemokine in Allergic Asthma

References

• Global strategy for asthma management and prevention. 2020. Available from: http://ginasthma.org/gina-reports/. Accessed November 1, 2021.
   Google Scholar
• Lee E, Kim A, Ye YM, Choi SE, Park HS. Increasing prevalence and mortality of asthma with age in Korea, 2002–2015: a nationwide, population-based study. Allergy Asthma Immunol Res. 2020;12(3):467–484.
   PubMed Web of Science ®Google Scholar
• Caminati M, Morais Almeida M, Bleecker E, et al. Biologics and global burden of asthma: a worldwide portrait and a call for action. World Allergy Organ J. 2021;14:2.
   Web of Science ®Google Scholar
• Kuruvilla ME, Lee FEH, Lee GB. Understanding asthma phenotypes, endotypes, and mechanisms of disease. Clin Rev Allergy. 2019;56(2):219–233.
   Google Scholar
• Weinberger SE, Cockrill BA, Mandel J. Asthma. In: Weinberger SE, Cockrill BA, Mandel J, editors. Principles of Pulmonary Medicine (Seventh Edition). Philadelphia: Elsevier; 2019:75–92.
   Google Scholar
• Ying S, Meng Q, Zeibecoglou K, et al. Eosinophil chemotactic chemokines (Eotaxin, Eotaxin-2, RANTES, monocyte chemoattractant protein-3 (MCP-3), and MCP-4), and C-C chemokine receptor 3 expression in bronchial biopsies from atopic and nonatopic (Intrinsic) asthmatics. J Immunol Res. 1999;163(11):6321–6329.
   Google Scholar
• Agrawal DK, Shao Z. Pathogenesis of allergic airway inflammation. Curr Allergy Asthma Rep. 2010;10(1):39–48.
   PubMed Web of Science ®Google Scholar
• Subramanian H, Gupta K, Ali H. Roles of Mas-related G protein–coupled receptor X2 on mast cell–mediated host defense, pseudoallergic drug reactions, and chronic inflammatory diseases. J Allergy Clin Immunol. 2016;138(3):700–710.
   PubMed Web of Science ®Google Scholar
• Tiotiu A. Biomarkers in asthma: state of the art. Asthma Res Pract. 2018;4:10.
   PubMedGoogle Scholar
• Umeda M, Origuchi T, Kawashiri S, et al. Thymus and activation-regulated chemokine as a biomarker for IgG4-related disease. Sci Rep. 2020;10(1):6010.
   PubMed Web of Science ®Google Scholar
• Imai T, Baba M, Nishimura M, Kakizaki M, Takagi S, Yoshie O. The T cell-directed CC chemokine TARC is a highly specific biological ligand for CC chemokine receptor 4. J Biol Chem. 1997;272(23):15036–15042.
   PubMed Web of Science ®Google Scholar
• Kataoka Y. Thymus and activation-regulated chemokine as a clinical biomarker in atopic dermatitis. J Dermatol. 2014;41(3):221–229.
   PubMed Web of Science ®Google Scholar
• Sekiya T, Yamada H, Yamaguchi M, et al. Increased levels of a Th2-type CC chemokine thymus and activation-regulated chemokine (TARC) in serum and induced sputum of asthmatics. Allergy. 2002;57(2):173–177.
   PubMed Web of Science ®Google Scholar
• Kawasaki S, Takizawa H, Yoneyama H, et al. Intervention of thymus and activation-regulated chemokine attenuates the development of allergic airway inflammation and hyperresponsiveness in mice. J Immunol. 2001;166(3):2055–2062.
   PubMed Web of Science ®Google Scholar
• Pham DL, Kim SH, Losol P, et al. Association of autophagy related gene polymorphisms with neutrophilic airway inflammation in adult asthma. Korean J Intern Med. 2016;31(2):375–385.
   PubMed Web of Science ®Google Scholar
• ATS/ERS. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med. 2005;171(8):912–930.
   PubMed Web of Science ®Google Scholar
• Morris JF. Spirometry in the evaluation of pulmonary function. West J Med. 1976;125(2):110–118.
   PubMedGoogle Scholar
• Woo SD, Yang EM, Jang J, et al. Serum-free immunoglobulin E: a useful biomarker of atopy and type 2 asthma in adults with asthma. Ann Allergy Asthma Immunol. 2021;127(1):109–115.
   PubMed Web of Science ®Google Scholar
• Holguin F, Cardet JC, Chung KF, et al. Management of severe asthma: a European Respiratory Society/American Thoracic Society guideline. Eur Respir J. 2020;55(1):1900588.
   PubMed Web of Science ®Google Scholar
• Luu QQ, Cao TBT, Shin YS, Yang EM, Moon JY, Park HS. Sputum ANA serves as a biomarker for severe asthma. Allergy. 2021. doi:10.1111/all.15086
   PubMed Web of Science ®Google Scholar
• Li H, Edin ML, Gruzdev A, et al. Regulation of T helper cell subsets by cyclooxygenases and their metabolites. Prostaglandins Other Lipid Mediat. 2013;104-105:74–83.
   PubMed Web of Science ®Google Scholar
• Debeuf N, Lambrecht BN. Eicosanoid control over antigen presenting cells in asthma. Front Immunol. 2018;9. doi:10.3389/fimmu.2018.02006(2006).
   PubMed Web of Science ®Google Scholar
• Froidure A, Mouthuy J, Durham SR, Chanez P, Sibille Y, Pilette C. Asthma phenotypes and IgE responses. Eur Respir J. 2016;47(1):304–319.
   PubMed Web of Science ®Google Scholar
• Broide DH. Molecular and cellular mechanisms of allergic disease. J Allergy Clin Immunol. 2001;108(2 Suppl):S65–71.
   PubMed Web of Science ®Google Scholar
• Brightling CE, Bradding P, Symon FA, Holgate ST, Wardlaw AJ, Pavord ID. Mast-cell infiltration of airway smooth muscle in asthma. N Engl J Med. 2002;346(22):1699–1705.
   PubMed Web of Science ®Google Scholar
• Amin K, Janson C, Boman G, Venge P. The extracellular deposition of mast cell products is increased in hypertrophic airways smooth muscles in allergic asthma but not in nonallergic asthma. Allergy. 2005;60(10):1241–1247.
   PubMed Web of Science ®Google Scholar
• Williams CMM, Galli SJ. Mast cells can amplify airway reactivity and features of chronic inflammation in an asthma model in mice. J Exp Med. 2000;192(3):455–462.
   PubMed Web of Science ®Google Scholar
• Yu M, Tsai M, Tam SY, Jones C, Zehnder J, Galli SJ. Mast cells can promote the development of multiple features of chronic asthma in mice. J Clin Investig. 2006;116(6):1633–1641.
   PubMed Web of Science ®Google Scholar
• Mayr SI, Zuberi RI, Zhang M, et al. IgE-dependent mast cell activation potentiates airway responses in murine asthma models. J Immunol Res. 2002;169(4):2061–2068.
   Google Scholar
• Lee Y, Quoc QL, Park HS. Biomarkers for severe asthma: lessons from longitudinal cohort studies. Allergy Asthma Immunol Res. 2021;13(3):375–389.
   PubMed Web of Science ®Google Scholar
• Lee Y, Lee JH, Yang EM, et al. Serum levels of eosinophil-derived neurotoxin: a biomarker for asthma severity in adult asthmatics. Allergy Asthma Immunol Res. 2019;11(3):394–405.
   PubMed Web of Science ®Google Scholar
• An J, Lee JH, Sim JH, et al. Serum eosinophil-derived neurotoxin better reflect asthma control status than blood eosinophil counts. J Allergy Clin Immunol Pract. 2020;8(8):2681–2688.
   PubMed Web of Science ®Google Scholar
• Vignola AM, Kips J, Bousquet J. Tissue remodeling as a feature of persistent asthma. J Allergy Clin Immunol. 2000;105(6 Pt 1):1041–1053.
   PubMed Web of Science ®Google Scholar
• Sanak M. Eicosanoid mediators in the airway inflammation of asthmatic patients: what is new? Allergy Asthma Immunol Res. 2016;8(6):481–490.
   PubMed Web of Science ®Google Scholar
• Kytikova O, Novgorodtseva T, Denisenko Y, Antonyuk M, Gvozdenko T. Pro-resolving lipid mediators in the pathophysiology of asthma. Medicina (Kaunas). 2019;55(6):284.
   PubMed Web of Science ®Google Scholar
• Chen LC, Tseng HM, Kuo ML, et al. Levels of 15-HETE and TXB2 in exhaled breath condensates as markers for diagnosis of childhood asthma and its therapeutic outcome. Pediatr Allergy Immunol. 2021;32(8):1673.
   PubMed Web of Science ®Google Scholar
• Celejewska Wójcik N, Kania A, Górka K, et al. Eicosanoids and eosinophilic inflammation of airways in stable COPD. Int J Chron Obstruct Pulmon Dis. 2021;16:1415–1424.
   PubMed Web of Science ®Google Scholar
• Dennis EA, Norris PC. Eicosanoid storm in infection and inflammation. Nat Rev Immunol. 2015;15(8):511–523.
   PubMed Web of Science ®Google Scholar
• Chu HW, Balzar S, Westcott JY, et al. Expression and activation of 15-lipoxygenase pathway in severe asthma: relationship to eosinophilic phenotype and collagen deposition. Clin Exp Allergy. 2002;32(11):1558–1565.
   PubMedGoogle Scholar
• Serhan CN, Chiang N, Van Dyke TE. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol. 2008;8(5):349–361.
   PubMed Web of Science ®Google Scholar
• Bocan TMA, Rosebury WS, Mueller SB, et al. A specific 15-lipoxygenase inhibitor limits the progression and monocyte–macrophage enrichment of hypercholesterolemia-induced atherosclerosis in the rabbit. Atherosclerosis. 1998;136(2):203–216.
   PubMed Web of Science ®Google Scholar
• Foster HR, Fuerst E, Branchett W, Lee TH, Cousins DJ, Woszczek G. Leukotriene E4 is a full functional agonist for human cysteinyl leukotriene type 1 receptor-dependent gene expression. Sci Rep. 2016;6(1):20461.
   PubMed Web of Science ®Google Scholar